Gene · 9075
Papers2,543
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,543
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME. | Nutrients | 2023 | 36986251 | PubTator, text mining | PubMed |
| P53 Deficiency Accelerates Esophageal Epithelium Intestinal Metaplasia Malignancy. | Biomedicines | 2023 | 36979860 | PubTator, text mining | PubMed |
| The CLDN5 gene at the blood-brain barrier in health and disease. | Fluids Barriers CNS | 2023 | 36978081 | PubTator, text mining | PubMed |
| Effects of dietary chlorogenic acid on intestinal barrier function and the inflammatory response in broilers during lipopolysaccharide-induced immune stress. | Poult Sci | 2023 | 36972676 | PubTator, text mining | PubMed |
| Gut microbiota and Autism Spectrum Disorder: From pathogenesis to potential therapeutic perspectives. | J Tradit Complement Med | 2023 | 36970459 | PubTator, text mining | PubMed |
| Exploring the components and mechanism of Solanum nigrum L. for colon cancer treatment based on network pharmacology and molecular docking. | Front Oncol | 2023 | 36969029 | PubTator, text mining | PubMed |
| Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells. | Oncotarget | 2023 | 36961882 | PubTator, text mining | PubMed |
| Multi-targeted therapy resistance via drug-induced secretome fucosylation. | Elife | 2023 | 36961502 | PubTator, text mining | PubMed |
| Claudin and pancreatic cancer. | Front Oncol | 2023 | 36959784 | PubTator, text mining | PubMed |
| Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment. | Gut Microbes | 2023 | 36951545 | PubTator, text mining | PubMed |
| Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy. | Front Nutr | 2023 | 36937361 | PubTator, text mining | PubMed |
| Advances in acute and chronic pancreatitis. | World J Gastroenterol | 2023 | 36926670 | PubTator, text mining | PubMed |
| The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update. | Front Immunol | 2023 | 36926328 | PubTator, text mining | PubMed |
| Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis. | Ther Adv Gastroenterol | 2023 | 36923487 | PubTator, text mining | PubMed |
| Human Colonoid-Myofibroblast Coculture for Study of Apical Na+/H+ Exchangers of the Lower Cryptal Neck Region. | Int J Mol Sci | 2023 | 36901695 | PubTator, text mining | PubMed |
Alleviation of cholestatic liver injury and intestinal permeability by lubiprostone treatment in bile duct ligated rats: role of intestinal FXR and tight junction proteins claudin-1, claudin-2, and occludin. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | 36897372 | PubTator, text mining | PubMed |
| Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer. | J Transl Med | 2023 | 36895039 | PubTator, text mining | PubMed |
| Chemical exposures and suspected impact on Gulf War Veterans. | Mil Med Res | 2023 | 36882803 | PubTator, text mining | PubMed |
| Understanding disruption of the gut barrier during inflammation: Should we abandon traditional epithelial cell lines and switch to intestinal organoids? | Front Immunol | 2023 | 36875103 | PubTator, text mining | PubMed |
| Claudin-10b cation channels in tight junction strands: Octameric-interlocked pore barrels constitute paracellular channels with low water permeability. | Comput Struct Biotechnol J | 2023 | 36874155 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9075/papers?page=20